U.S. Senator requests FDA to Scrutinize Glaxo's Antidepressant Data
U.S. senator Charles Grassley asked to scrutinize if the drug maker GlaxoSmithKline Plc withheld safety information that linked its drug Paxil to suicide risk.
GlaxoSmithKline Breast Cancer Pill Gets EU Backing
GlaxoSmithKline Plc's breast cancer vaccine was recommended for approval by European drug regulators on Thursday but they warned of potential liver toxicity, according to a report.
GlaxoSmithKline PLC 1Q Profit Fall on Generics Competition
GlaxoSmithKline PLC reported its first-quarter profit fell 13.7 percent from a year ago as sales of the group's main drug for diabetes Avandia fell.
Sirtris Pharmaceuticals Shares rose 80% after Glaxo offers $720 Million
Shares of Sirtris Pharmaceuticals rose as much as 80.46 percent to $22.07 in after trading hours on Tuesday in the New York Stock Exchange as healthcare group GlaxoSmithKline Plc. entered into a definitive agreement to acquire Sirtris for $720 million in a cash tender offer of $22.50 per share.
FTSE steady on Monday
The FTSE 100 share index was almost unchanged as Monday came to an end, with the index going down only 3.5 points to 6,053.0 (down 0.06 per cent).
FTSE begins 2Q with a Rise
The FTSE 100 share index did well on Tuesday, rising 150.5 points to 5,852.6 (up 2.6 per cent).
India's Dr Reddy's posts Q3 loss, German unit weighs
India's Dr Reddy's Laboratories Ltd posted an unexpected net loss for the December quarter as it wrote off $60 million of costs for its underperforming German unit and saw revenues decline.
Glaxo acquires marketing rights from Merck
GlaxoSmithKline Plc Monday reached an agreement with Merck for the acquisition of marketing rights for Mecavor in the United States.
Drug firms seek new model as blockbusters wilt
A younger generation of chief executives in many boardrooms is set to spur the strategic overhaul.
China tries charm to convince world its goods safe
China went on a charm offensive on Wednesday to convince a skeptical world its products are safe, as a new poll in the United States found 78 percent of Americans were worried about the safety of Chinese goods.
Glaxo diabetes drug should stay on market: U.S. panel
GlaxoSmithKline Plc's diabetes drug Avandia should stay on the U.S. market, even though data suggest it may increase the risk of a heart attack for some patients, an advisory panel said on Monday in a 22-1 vote.
FDA scientist says pull Avandia
GlaxoSmithKline Plc's widely used diabetes drug Avandia should be pulled off the market, U.S. Food and Drug Administration scientist David Graham said in a presentation prepared for delivery on Monday.
FDA to ask if Avandia should stay on market
The U.S. Food and Drug Administration will ask outside advisers if GlaxoSmithKline Plc's diabetes drug Avandia should be taken off the market or remain on sale with new warnings or limits, a summary released on Thursday said.
U.S. Approves First Non-Prescription Diet Pill
The first U.S. non-prescription weight loss pill was approved this week by U.S. health officials.
Mixed verdict for Glaxo in EU drug export case
GlaxoSmithKline won a partial victory on Wednesday in its bid to stop Spanish drug wholesalers from re-exporting its medicines at high premiums.
GSK Submits Tykerb for Market Approval
GlaxoSmithKine plc has announced today the submission of a New Drug Application to the United States Food and Drug Administration (FDA), for approval to market.
Glaxo to supply cut-price AIDS drugs to Russia
GlaxoSmithKline Plc, the world's leading maker of HIV/AIDS treatments, has struck a deal to supply cut price AIDS drugs to Russia
US Approves Merck's Cervical Cancer Vaccine
The first vaccine to prevent cervical cancer won U.S. approval on Thursday when health officials cleared a Merck & Co. Inc. shot to block a sexually transmitted infection that causes the deadly disease.
Bayer Not Seeking Pfizer Consumer Health Unit
German drugs and chemicals group Bayer is not currently considering a bid for Pfizer's consumer healthcare business, an industry source familiar with the matter told Reuters on Saturday.